US 100% tariff on generic drugs threatens Indian pharmaceutical exports
Compare the reporting
Discrepancy in tariff percentage figures.
Open the listed sources to review each publisher’s original wording.
Story essentials
Indian pharmaceutical industry
USA / India
July 2026
This page is produced by collecting and structuring multiple public reports. Sections based only on reporting or testimony affect the displayed assessment, and the page is updated when new information is identified.
About this article
COMPAMIR Editorial Team
The COMPAMIR editorial team brings together public reporting and links to the original coverage. We update the page as new information emerges.
Read our editorial policy- Earlier version 17/22/2026, 1:41:10 PM
The US is considering a 100% tariff on generic drug imports, which could significantly impact India's pharmaceutical industry. The US accounted for 37% of India's $26 billion pharma exports in 2025. Indian drugmakers face pressure to shift production or expand into higher-value medicines.
Read next
Prioritized by shared people, places, and events.
US diesel prices hit record highs amid ongoing conflict with Iran
US diesel prices reached a record average of $5.85 per gallon. The six-month conflict with Iran has disrupted global fuel supply chains. Rising fuel costs are impacting freight, delivery networks, and food prices.